NCT00327561

Brief Summary

The hypothesis of the existence of a causal association between the systemic infectious/inflammatory burden represented by periodontitis and endothelial function assessed by flow mediated dilatation of the brachial artery (FMD) is the subject of the proposed investigation. The objective of this randomized controlled clinical trial is to evaluate the effects of periodontal therapy on endothelial function assessed by Flow mediated dilatation (FMD). The rationale for this project is twofold:

  • Establish the extent of acute systemic inflammation and endothelial dysfunction associated with the delivery of subgingival instrumentation for the treatment of chronic periodontitis
  • Establish whether or not improved control of chronic periodontal infections results in improved endothelial function and thus the existence of a causal association between periodontitis and endothelial dysfunction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Sep 2003

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2003

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2005

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

May 16, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 18, 2006

Completed
Last Updated

May 18, 2006

Status Verified

March 1, 2005

First QC Date

May 16, 2006

Last Update Submit

May 16, 2006

Conditions

Keywords

InflammationPeriodontitisEndothelial functionAtherosclerosisControlled trial

Outcome Measures

Primary Outcomes (1)

  • Flow mediated dilatation of the brachial artery

Secondary Outcomes (1)

  • Serum inflammatory and endothelial function markers

Interventions

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Between the ages of 35 and 60 and in good general health.
  • Ability and willingness to follow study procedures and instructions.
  • Must have read, understood and signed the Informed Consent.
  • Must have generalized, moderate to advanced chronic periodontitis.
  • pockets with a PD of \> 5 must bleed on probing.
  • Absence of other significant oral infections.

You may not qualify if:

  • Pregnant or lactating females or females of child bearing potential not using acceptable methods of birth control (hormonal, barriers or abstinence).
  • Patients chronically treated (i.e., two weeks or more) with any vasoactive medication (i.e., antihypertensive) or lipid lowering therapy.
  • Patients who started taking nonsteroidal anti-inflammatory drugs within two months prior to the baseline visit.
  • Diagnosis of uncontrolled metabolic diseases including diabetes, kidney, liver, or cardiovascular diseases.
  • Use of systemic antibiotics in the preceding 3 month.
  • Patients taking steroid medications except for acute topical treatment.
  • Patients with active infectious diseases such as hepatitis, HIV, or TB.
  • Patients who require antibiotic pre-medication for the performance of periodontal examination or treatment.
  • Patients who received a course of periodontal treatment within the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UCL Eastman Dental Institute and Hospital

London, WC1X 8LD, United Kingdom

Location

UCL Vascular Biology Laboratory - Great Ormond Street Hospital

London, United Kingdom

Location

Related Publications (7)

  • D'Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J. 2006 May;151(5):977-84. doi: 10.1016/j.ahj.2005.06.018.

    PMID: 16644317BACKGROUND
  • D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res. 2005 Mar;84(3):269-73. doi: 10.1177/154405910508400312.

    PMID: 15723869BACKGROUND
  • D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004 Feb;83(2):156-60. doi: 10.1177/154405910408300214.

    PMID: 14742655BACKGROUND
  • D'Aiuto F, Tonetti MS. Contribution of periodontal therapy on individual cardiovascular risk assessment. Arch Intern Med. 2005 Sep 12;165(16):1920-1. doi: 10.1001/archinte.165.16.1920. No abstract available.

    PMID: 16157839BACKGROUND
  • D'Aiuto F, Parkar M, Brett PM, Ready D, Tonetti MS. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine. 2004 Oct 7;28(1):29-34. doi: 10.1016/j.cyto.2004.06.005.

    PMID: 15341923BACKGROUND
  • D'Aiuto F, Parkar M, Tonetti MS. Periodontal therapy: a novel acute inflammatory model. Inflamm Res. 2005 Oct;54(10):412-4. doi: 10.1007/s00011-005-1375-4.

    PMID: 16283108BACKGROUND
  • D'Aiuto F, Parkar M, Andreou G, Brett PM, Ready D, Tonetti MS. Periodontitis and atherogenesis: causal association or simple coincidence? J Clin Periodontol. 2004 May;31(5):402-11. doi: 10.1111/j.1600-051X.2004.00580.x.

    PMID: 15086624BACKGROUND

MeSH Terms

Conditions

PeriodontitisInflammationAtherosclerosis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Maurizio Tonetti, DMD PhD

    University College London Hospitals and University of Connecticut Health Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 16, 2006

First Posted

May 18, 2006

Study Start

September 1, 2003

Study Completion

March 1, 2005

Last Updated

May 18, 2006

Record last verified: 2005-03

Locations